Monoamine oxidase inhibitory naphthoquinones from the roots of Lithospermum erythrorhizon

Archives of Pharmacal Research

Volumn 28, Issue 4, 2005, Pages 400-404

  Woo, Hoi Choi ^a   Seong, Su Hong ^a   Lee, Seon A ^a   Xiang, Hua Han ^a   Kyong, Soon Lee ^a   Myung, Koo Lee ^a   Bang, Yeon Hwang ^a   Jai, Seup Ro ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Boraginaceae; Lithospermum erythrorhizon; Monoamine oxidase inhibitor; Naphthoquinone

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); MONOAMINE OXIDASE INHIBITOR; NAPHTHOQUINONE;

ANIMAL; ARTICLE; BRAIN; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENZYME SPECIFICITY; ENZYMOLOGY; IN VITRO STUDY; INSTITUTE FOR CANCER RESEARCH MOUSE; ISOLATION AND PURIFICATION; LITHOSPERMUM; MALE; METABOLISM; MOUSE; PLANT ROOT;

ANIMALS; BRAIN; LITHOSPERMUM; MALE; MICE; MICE, INBRED ICR; MOLECULAR STRUCTURE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NAPHTHOQUINONES; PLANT ROOTS; SUBSTRATE SPECIFICITY;

EID: 22844447960     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02977668     Document Type: Article

References (23)

1. Abell, C. W. and Kwan, S. W., Molecular characterization of monoamine oxidase A and B. Prog. Nucl. Acids Res. Mol. Biol., 65, 129-156 (2001).
2. Bach, A. W., Lan, N. C., Johnson, D. L., Abell, C. W., Bembenek, M. E., Kwan, S. W., Seeburg, P. H. and Shih, J. C., cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. U.S.A., 85, 4934-4938 (1988).
3. Cho, M. H., Paik, Y. S., and Hahn, T. R. Physical stability of shikonin derivatives from the roots of Lithospermum erythrorhizon cultivated in Korea. J. Agric. Food Chem., 47, 4117-4120 (1999).
4. Foley, P., Gerlach, M., Youdim, M. B. H., and Riederer, P., MAOB inhibitors: multiple roles in the therapy of neurodegenerative disorders? Parkinson Rel. Disorders, 6, 25-47 (2000).
5. Han, Y. N., Ryu, S. Y., and Han, B. H., Antioxidant activity of resveratrol closely relates with its monoamine oxidase-A inhibitory activity. Arch. Pharm. Res., 13, 132-135 (1990).
6. Inoue, K., Akaji, M., and Inouye, H. Quinones and related compounds in higher plants. XXI.: new findings on the proton and carbon-13 nuclear magnetic resonance spectra of shikonin. Chem. Pharm. Bull., 33, 3993-3997 (1985).
7. Jo, Y. S., Huong, D. T., Bae, K., Lee, M. K., and Kim, Y. H., Monoamine oxidase inhibitory coumarin from Zanthoxylum schinifolium. Planta Med., 68, 84-85 (2002).
8. Johnston, J. P., Some observations upon a new inhibitor of monoamine oxidases in brain tissue. Biochem. Pharmacol., 17, 1285-1297 (1968).
9. Knoll, J. and Magyar, K., Some puzzling pharmacological effects of monoamine oxidase inhibitors. Ad. Biochem. Psychopharmacol., 5, 393-417 (1972).
10. Kraml, M., A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacol., 14, 1684-1686 (1965).
11. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
12. Murphy, D. L., Substrate-selective monoamine oxidases. Biochem. Pharmacol., 27, 1889-1893 (1978).
13. Murphy, D. L., Sunderland, T., and Cohen, R. M., Monoamine oxidase-inhibiting antidepressants: A clinical update. Psychiatr. Clin. North Am., 7, 549-562 (1984).
14. Naoi, M. and Nagatsu, T., Quinoline and quininaldines as naturally occurring inhibitors specific for type A monoamine oxidase. Life Sci., 40, 1075-1082 (1987).
15. Nunez, M. B., Maguna, F. P., Okulik, N. B., and Castro, E. A., QSAR modeling of the MAO inhibitory activity of xanthones derivatives. Bioorg. Med. Chem. Lett., 14, 5611-5617 (2004).
16. Ro, J. S., Lee, S. S., Lee, K. S., and Lee, M. K., Inhibition of type A monoamine oxidase by coptisine in mouse brain. Life Sci., 70, 639-645 (2001).
17. Sankawa, U., Ebizuka, Y., Miyazaki, T., Isomura, Y. and Otsuka, H., Antitumor activity of shikonin and its derivatives. Chem. Pharm. Bull., 25, 2392-2395 (1977).
18. Suzuki, O., Katsumata, Y., Oya, M., Chari, V. M., Vermes, B., Wagner, H., and Hostettmann, K., Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones. Planta Med., 42, 17-21 (1981).
19. Tanaka, S., Tajima, M., Tsukada, M., and Tabata, M., A comparative study on anti-inflammatory activities of the enantiomers, shikonin and alkannin. J. Nat. Prod., 49, 466-469 (1986).
20. Tang, W. and Eisenbrand, G., Chinese drugs of plant origin. Springer-Verlag, New York, pp. 613-619 (1992).
21. Thull, U., Kneubuhler, S., Gaillard, P., Carrupt, P. A., Testa, B., Altomare, C., Carotti, A., Jenner, P., and McNaught, K. S., Inhibition of monoamine oxidase by isoquinoline derivatives: Qualitative and 3D-quantitative structure-activity relationships. Biochem. Pharmacol., 50, 869-877 (1995).
22. Wouters, J., Structural aspects of monoamine oxidase and its reversible inhibition. Curr. Med. Chem., 5, 137-162 (1998).
23. Yazaki, K., Fukui, H., and Tabata, M. Isolation of the intermediates and related metabolites of shikonin biosynthesis from Lithospermum erythrorhizon cell cultures. Chem. Pharm. Bull., 34, 2290-2293 (1986).